Efficacy of Ultrasound Guided Hyaluronic Injection in Treatment of Trigger Finger
Comparing the Efficacy of Ultrasound Guided Hyaluronic Injection With Ultrasound Guided Corticosteroid Injection in Treatment of Trigger Finger
1 other identifier
interventional
120
1 country
1
Brief Summary
Comparing the Efficacy of Ultrasound Guided Hyaluronic Injection with Ultrasound Guided Corticosteroid Injection in Treatment of Trigger Finger
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_2
Started Oct 2016
Shorter than P25 for phase_2
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2016
CompletedFirst Submitted
Initial submission to the registry
April 24, 2017
CompletedFirst Posted
Study publicly available on registry
April 27, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2017
CompletedMay 3, 2017
May 1, 2017
9 months
April 24, 2017
May 1, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Success rate
reduction of symptom which needed no further treatment at follow up
1 month, 3 month, 6 months
Secondary Outcomes (2)
Pain score
1 month, 3 month, 6 months
Functional outcome
1 month, 3 months, 6 months
Study Arms (2)
Hyaluronic acid
EXPERIMENTALHyaluronic acid
Triamcinolone acetonide
ACTIVE COMPARATOR10mg/ml Triamcinolone acetonide
Interventions
1 ml of Low molecular weight hyaluronic acid injection under ultrasound guidance after subcutaneous 0.5ml of 1%lidocaine injection
1ml of 10 mg of triamcinolone injection under ultrasound guidance after subcutaneous 0.5 ml 1%lidocaine injection
Eligibility Criteria
You may qualify if:
- Age \> 20 years old
- Quinnell grade I, II, III
- Acute (\< 6 months)
You may not qualify if:
- Quinnell grade IV
- Diabetes mellitus
- Rheumatoid arthritis
- Pregnancy
- Patient with prior injection or surgery of trigger finger
- Patient who are allergy to hyaluronic acid
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Faculty of medicine Ramathibodi hospital, Mahidol University
Ratchathewi, Bangkok, 10400, Thailand
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Thepparat Kanchanathepsak, M.D.
Ramathibodi Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 24, 2017
First Posted
April 27, 2017
Study Start
October 1, 2016
Primary Completion
June 30, 2017
Study Completion
September 30, 2017
Last Updated
May 3, 2017
Record last verified: 2017-05
Data Sharing
- IPD Sharing
- Will not share